Ali Osman

Ali Osman is an investment professional with over 15 years of global experience in private equity. Currently, Ali serves as the Chief Investment Officer, Technology at MGX, while also holding board positions at Avalara and as a Board Observer at Nielsen. Previously, Ali was a Board Member at Sterling Pharma Solutions and Outset Medical, Inc., as well as a Board Member at Envision Pharma Group. With a solid educational background, Ali is pursuing an MBA from Harvard Business School and holds a Bachelor of Science in Mechanical Engineering from Tufts University. Additionally, Ali was the Head of Technology, Direct Investments at Mubadala from 2009 to 2024.